Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood–Brain Barrier Endothelium
Zengtao Wang(University of Minnesota), Karunya K. Kandimalla(University of Minnesota)
Cited by 11
Related Papers
Apolipoprotein A-I Crosses the Blood-Brain Barrier through Clathrin-Independent and Cholesterol-Mediated Endocytosis
|Journal of Pharmacology and Experimental Therapeutics|2019|61
Mapping the dynamics of insulin-responsive pathways in the blood–brain barrier endothelium using time-series transcriptomics data
|npj Systems Biology and Applications|2022|22
Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood–Brain Barrier
|Molecular Pharmaceutics|2024|10
Molecular Mechanisms Underlying Amyloid Beta Peptide Mediated Upregulation of Vascular Cell Adhesion Molecule-1 in Alzheimer Disease
|Journal of Pharmacology and Experimental Therapeutics|2024|8
QSP Modeling Shows Pathological Synergism Between Insulin Resistance and Amyloid‐Beta Exposure in Upregulating VCAM1 Expression at the BBB Endothelium
|CPT Pharmacometrics & Systems Pharmacology|2024|3